PE
RXST icon

Point72 Europe’s RxSight RXST Stock Holding History

Point72 Europe’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.02K Buy
+114
New +$1K ﹤0.01% 693
2024
Q2 		– Sell
-85,662
Closed -$4.42M – 160
2024
Q1 		$4.42M Buy
+85,662
New +$4.2M 0.39% 83

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Europe's RXST Position: Q3 2025 in Review

Point72 Europe opened a new position in RxSight (RXST) in Q3 2025: 114 shares worth $1.02K. The stake represents ﹤0.01% of the portfolio and ranks #693 among its holdings. This is a return to the name: Point72 Europe previously reported a position in RXST as recently as Q1 2024.

Point72 Europe first reported a position in RXST in Q1 2024 and has held it in 2 quarters since. The position peaked at $4.42M in Q1 2024. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

  • Point72 Europe held 114 shares of RxSight worth $1.02K as of Q3 2025.
  • RxSight was a new Point72 Europe position in Q3 2025.
  • RxSight made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #693 holding.
  • Point72 Europe first reported a position in RxSight in Q1 2024 and has held it in 2 quarters since.
  • Point72 Europe's RxSight position peaked at $4.42M in Q1 2024.
  • 160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.